Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV‐infected adults in Uganda: a cross‐sectional study
Open Access
- 1 January 2012
- journal article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 15 (1) , 15
Abstract
Background: Cryptococcal infection is a common opportunistic infection among severely immunosuppressed HIV patients and is associated with high mortality. Positive cryptococcal antigenemia is an independent predictor of cryptococcal meningitis and death in patients with severe immunosuppression. We evaluated the prevalence and factors associated with cryptococcal antigenemia among patients with CD4 counts of 100 cells/mm3 or less in Mulago Hospital, Kampala, Uganda. Screening of a targeted group of HIV patients may enable early detection of cryptococcal infection and intervention before initiating antiretroviral therapy. Factors associated with cryptococcal antigenemia may be used subsequently in resource‐limited settings in screening for cryptococcal infection, and this data may also inform policy for HIV care.Methods: In this cross‐sectional study, HIV‐infected patients aged 18 years and older with CD4 counts of up to 100 cells/mm3 were enrolled between December 2009 and March 2010. Data on socio‐demographics, physical examinations and laboratory tests were collected. Factors associated with cryptococcal antigenemia were analyzed using multiple logistic regression.Results: We enrolled 367 participants and the median CD4 count was 23 (IQR 9‐51) cells/mm3. Sixty‐nine (19%) of the 367 participants had cryptococcal antigenemia. Twenty‐four patients (6.5%) had cryptococcal meningitis on cerebrospinal fluid analysis and three had isolated cryptococcal antigenemia. Factors associated with cryptococcal antigenemia included: low body mass index of 15.4 kg/m2 or less (adjusted odds ratio, AOR = 0.5; 95% CI 0.3‐1.0), a CD4+ T cell count of less than 50 cells/mm3 (AOR = 2.7; 95% CI1.2‐6.1), neck pain (AOR = 2.3; 95% CI 1.2‐4.6), recent diagnosis of HIV infection (AOR = 1.9; 95% CI 1.1‐3.6), and meningeal signs (AOR = 7.9; 95% CI 2.9‐22.1). However, at sub‐analysis of asymptomatic patients, absence of neck pain (AOR = 0.5), photophobia (AOR = 0.5) and meningeal signs (AOR = 0.1) were protective against cryptococcal infection.Conclusions: Cryptococcal antigenemia is common among severely immunosuppressed HIV patients in Mulago Hospital, Kampala, Uganda. Independent predictors of positive serum cryptococcal antigenemia were CD4+ T cell counts of less than 50 cells/mm, low body mass index, neck pain, signs of meningeal irritation, and a recent diagnosis of HIV infection. Routine screening of this category of patients may detect cryptococcosis, and hence provide an opportunity for early intervention. Absence of neck pain, photophobia and meningeal signs were protective against cryptococcal infection compared with symptomatic patients.Keywords
Funding Information
- Fogarty International Center (FIC) at the National Institutes of Health (TW00011)
- Harvard Initiative for Global Health
This publication has 17 references indexed in Scilit:
- Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in CambodiaPLOS ONE, 2010
- Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited SettingsClinical Infectious Diseases, 2010
- Nutritional aspects of HIV-associated wasting in sub-Saharan AfricaThe American Journal of Clinical Nutrition, 2010
- Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter StudyClinical Infectious Diseases, 2009
- Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South AfricaClinical Infectious Diseases, 2009
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS, 2009
- Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2008
- Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural UgandaTropical Medicine & International Health, 2007
- Effector T lymphocytes in well-nourished and malnourished infected childrenClinical and Experimental Immunology, 2007
- The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000Clinical Infectious Diseases, 2003